GDNF: where are we 1 year on? Date 25 February 2020 GDNF clinical trial results in 2019 revealed signs that GDNF may make it possible to repair the cells damaged in people with Parkinson’s. We take a look at where we are 1 year later.
BT13 molecule offers hope for halting Parkinson’s Date 14 February 2020 A promising molecule, called BT13, has offered hope for a new treatment that could stop or slow Parkinson’s, something no treatment can currently do.
Gut bacteria could guard against Parkinson’s Date 14 January 2020 New research suggests that a bacteria which boosts digestive health can slow – and even reverse – the build-up of a protein associated with Parkinson’s.
Poll finds a quarter of people with Parkinson’s are wrongly diagnosed Date 10 January 2020 In our survey of more than 2,000 people, more than a quarter (26%) reported they were misdiagnosed with a different condition before receiving the correct Parkinson’s diagnosis.
8 remarkable things we achieved together in 2019, and recent years Date 17 December 2019 2019 was another exciting year of progress. Here are 8 of the highlights, and 8 ways you can still get involved.
Progress in gene therapy treatment for Parkinson's Date 5 December 2019 Researchers, funded by Parkinson's UK, have produced positive results in mice for a gene therapy treatment that directly targets the production of the alpha-synuclein protein.
Could sleep boost waste disposal in the brain and prevent Parkinson’s? Date 1 November 2019 Alongside Alzheimer’s Research UK, we’re funding new research that will investigate whether boosting the brain’s self-cleaning system could be the key to new treatments.
Revolutionary research advocate Ken Bowler dies aged 76 Date 23 October 2019 The Parkinson’s community in Scotland, and beyond, has lost one of its giants with the passing of Professor Ken Bowler. Ken revolutionised the relationship between researchers and people living with Parkinson’s.
Ex-footballers more likely to get Parkinson's, research finds Date 22 October 2019 Former professional footballers are more likely to die with a neurodegenerative condition such as dementia or Parkinson's than the general population, according to new research.
Can cannabis stop Parkinson's hallucinations? Date 14 October 2019 A pioneering clinical trial will investigate if cannabidiol (CBD) – a compound found in the cannabis plant – can treat hallucinations and delusions in people living with Parkinson’s.
